Skip to content

Clinical trials

Respiratory Tract Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Neoplasms Country / region: Taiwan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20174
20212
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation2
Eli Lilly and Company2
Revolution Medicines, Inc.2
AVEO Pharmaceuticals, Inc.1
ArriVent BioPharma, Inc.1
AstraZeneca1
Hoffmann-La Roche1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung11
Lung Neoplasms11
Respiratory Tract Neoplasms11
Bronchial Neoplasms10
Lung Diseases10
Neoplasms by Site10
Respiratory Tract Diseases10
Neoplasms9
Thoracic Neoplasms9
Carcinoma, Bronchogenic7

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.